APA (7th ed.) Citation

Wang, Y., Lin, C., Su, Y., & Teng, C. J. Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: A systemic review and meta-analysis. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Wang, Yin-Che, Cheng-Hsien Lin, Yu-Chen Su, and Chieh-Lin Jerry Teng. Bortezomib, Thalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant-eligible Newly Diagnosed Multiple Myeloma: A Systemic Review and Meta-analysis. Taylor & Francis Group.

MLA (9th ed.) Citation

Wang, Yin-Che, et al. Bortezomib, Thalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant-eligible Newly Diagnosed Multiple Myeloma: A Systemic Review and Meta-analysis. Taylor & Francis Group.